The effect of alprenolol on serum myoglobin levels in acute myocardial infarction

References

• Andersen M. P., Bechsgaard P., Frederiksen J., Hansen D. A., Jurgensen H. J., Nielsen B., Pedersen F., Pcdersen‐Bjergaard O., Rasmussen S. L. Effect of alprenolol on mortality among patients with definite or suspected acute myocar‐dial infarction. Lancet 1979; ii: 865
   Google Scholar
• Chapelle J. P., Albert A., Smeets J. P., Boland J., Heusgem C., Kulbertus H. E. Serum myoglobin determinations in the assessment of acute myocardial infarction. Eur. Heart J. 1982; 3: 122
   PubMedGoogle Scholar
• Grande P., Hansen B. F., Christiansen C., Nastoft J. Estimation of acute myocardial infarct size in man by serum CK‐MB measurements. Circulation 1982; 65: 756
   PubMed Web of Science ®Google Scholar
• Hallgren R., Karlsson F. A., Roxin L. E., Venge P. Myoglobin turnover‐influence of renal and extrarenal factors. J. Lab. clin. Med. 1978; 91: 246
   PubMed Web of Science ®Google Scholar
• Hearse D. J. Myocardial enzyme leakage. J. mol. Med. 1977; 2: 185
   Google Scholar
• Hjalmarson Å., Elmfeldt D., Herlitz J., Holmberg S., Malek I., Nyberg G., Ryden L., Swedberg K., Vedin A., Waagstein F., Waldenstrom A., Waldenstrom J., Wedel H., Wilhelmsen L., Wilhelmsson C. Effect on mortality of metoprolol in acute myocardial infarction. Lancet 1981; ii: 823
   Google Scholar
• Hørder M., Petersen P. H., Thygesen K., Nielscn B. L. Plasma enzymes in myocardial infarction. An appraisal of quantitative, clinical and patho‐physiological information. Scand. J. chi. Lab. Invest. 1981; 41: 41
   PubMed Web of Science ®Google Scholar
• Juhl E., Christensen E., Tygstrup N. How are negative controlled clinical investigations interpreted? Hepato‐, gastro‐, enterological randomized investigations from a ten‐year period with insignificant results. Ugeskr. Laeger 1982; 144: 2913
   Google Scholar
• Kaiser H., Spaar U., Sold G., Wolfrum D. I., Kreuzer H. Radioimmunologische Bestimmung von Human‐Myoglobin in der Diagnostik des akuten Myokardinfarkts. Klin. Wochenschr. 1979; 57: 225
   Google Scholar
• Maddison A., Craig A., Yusuf S., Lopez R., Sleight P. The role of serum myoglobin in the detection and measurement of myocardial infarction. Clinica Chim. Acta 1980; 106: 17
   PubMedGoogle Scholar
• McMurtry J. P., Wexler B. C. Detection of early myocardial infarction by radioimmunoassay of myoglobin. Angiology 1979; 30: 806
   Google Scholar
• Norris R. M., Clarke E. D., Sammel N. L., Smith W. M., Williams B. Protective effect of propranolol in threatened myocardial infarction. Lancet 1978; ii: 907
   Google Scholar
• Nørregaard‐Hansen K., Lindø K. E., Ludvigsen C. V., Nørgaard‐Pedersen B. Serum myoglobin compared with creatine kinase in patients with acute myocardial infarction. Acta med. scand. 1980; 207: 165
   Google Scholar
• Page D. L., Caulfield J. B., Kastor J. A., De‐Sanctis R. W., Sanders C. A. Myocardial changes associated with cardiogenic shock. N. Eng. J. Med. 1971; 285: 133
   PubMed Web of Science ®Google Scholar
• Peter T., Norris R. M., Clarke E. D., Heng M. K., Singh B. N., Williams B., Howell D. R., Ambler P. K. Reduction of enzyme levels by propranolol after acute myocardial infarction. Circulation 1978; 57: 1091
   PubMed Web of Science ®Google Scholar
• Roe G. R. Validity of estimating myocardial infarct size from serial measurements of enzyme activity in the serum. Clin. Chem. 1977; 23: 1807
   PubMed Web of Science ®Google Scholar
• Rosalki S. B. An improved procedure for serum creatine phosphokinase determination. J. Lab. clin. Med. 1967; 69: 696
   PubMed Web of Science ®Google Scholar
• Rosano T. G., Kenny M. A. A radioimmunoassay for human serum myoglobin: method development and normal values. Clin. Chem. 1977; 23: 69
   PubMed Web of Science ®Google Scholar
• Shell W. E., Lavelle J. F., Covell J. W., Sobel B. E. Early estimation of myocardial damage in conscious dogs and patients with evolving acute myocardial infarction. J. din. Invest. 1973; 52: 2579
   PubMedGoogle Scholar
• Sobel B. E., Bresnahah G. F., Shell W. E., Yoder R. D. Estimation of infarct size in man and its relation to prognosis. Circulation 1972; 46: 640
   PubMed Web of Science ®Google Scholar
• Stone M. J., Waterman M. R., Poliner L. R., Templeton G. H., Buja L. M., Willerson J. T. Myoglobinemia is an early and quantitative index of acute myocardial infarction. Angiology 1978; 29: 386
   PubMedGoogle Scholar
• Stone M. J., Willerson J. T., Gomez‐Sanchez C. E., Waterman M. R. Radioimmunoaxsay of myoglobin in human serum. J. din. Invest. 1975; 56: 1334
   PubMed Web of Science ®Google Scholar
• Sylven C., Bendz R. Myoglobin, creatine kinase and its isoenzyme MB in serum after acute myocardial infarction. Eur. J. Cardiol. 1978; 8: 515
   PubMedGoogle Scholar
• Sylven J. C.H. Myoglobin and creatine kinase rates of release during acute myocardial infarction. Clin. Cardiol. 1980; 3: 324
   PubMedGoogle Scholar
• Thompson P. L., Fletcher E. E., Katavatis V. Enzymatic indices of myocardial necrosis: influence on short‐ and long‐term prognosis after myocardial infarction. Circulation 1979; 59: 113
   PubMed Web of Science ®Google Scholar
• Tommaso C. L., Salzeider K., Arif M., Klutz W. Serial myoglobin vs. CPK analysis as an indicator of uncomplicated myocardial infarction size and its use in assessing early infarct extension. Am. Heart J. 1980; 99: 149
   Google Scholar
• Witherspoon L. R., Shuler S. E., Garcia M. M., Zollinger L. A. Assessment of serum myoglobin as a marker for acute myocardial infarction. J. nucl. Med. 1979; 20: 115
   Google Scholar
• World Health Organization. Ischemic Heart Disease Register. Copenhagen 1971
   Google Scholar
• Von der Lippe G., Stensland E., Romslo I. Har bestemmelse av kreatin kinase‐B (CK‐B) og myoglobin noen fordel fremfor bestemmclse af ASAT i rutinediagnostikken, av akutt hjertcinfarkt?. Tidsskr. Nor. Legeforen. 1981; 101: 93
   Google Scholar
• Yusuf S., Ramsdale D., Peto R., Furse L., Bennett D., Bray C., Sleight P. Early intravenous atenolol treatment in suspected acute myocardial infarction. Luncel 1980; ii: 273
   Google Scholar